Skip to main content
. 2003 Apr 22;2003(2):CD004264. doi: 10.1002/14651858.CD004264
Methods Generation of allocation sequence: randomized (method not specified but used serially numbered envelopes)
Allocation concealment: adequate
Blinding: parallel, placebo‐controlled trial
Length of follow up: 2 hours
Participants 130 children aged 6 months to 5 years, rectal temperature 39.4 °C or more, lasting more than 3 days, of viral and bacterial origin
Exclusion criteria: received antipyretic 4 hours before study entry
Interventions 1. Placebo (n = 15) 2. Tepid water sponging plus placebo (n = 15) 3. Paracetamol alone (n = 25) 4. Tepid sponging plus paracetamol (n = 25) 5. Iced water plus paracetamol (n = 25) 6. Alcohol in water plus paracetamol (n = 25)
Paracetamol dose: 80 mg (6 to 18 months), 160 mg (18 to 30 months), 240 mg (30 to 48 months) and 320 mg (48 to 60 months)
Outcomes Percentage with temperature </= 38.3 °C at 1 and 2 hours; percentage with comfort rated as good, fair, or poor
Notes Study location: Honolulu, Hawaii
No losses to follow up or withdrawals recorded